Three drivers of innovation in the biotech industry—technological advancements in research tools, an increasing supply of investment capital, and a maturing contract research and development field—are creating investment opportunities that will help shape the future of medicine.
The T. Rowe Price Global Equity Fund is a high conviction, truly global equity portfolio seeking to invest in companies with above-average and sustainable growth characteristics. The Fund’s objective is to provide long-term capital appreciation. It comes in both hedged and unhedged versions.
